Corporate sales fell to $1.97 billion. Nearly three-quarters of corporate sales occurred in markets outside the US. Sales of beauty and related products declined 16%. AgeLOC beauty products accounted for 46% of beauty product sales and 20% of corporate sales. Nu Skin blamed the decline on continued macroeconomic pressure. Every geographic region reported a decline in sales, led by 22% declines in the Americas and Southeast Asia/Pacific.

In recent years, Nu Skin has expanded its reach through Rhyz; the new business unit develops functional foods, and manufactures dietary supplements and custom packaging. In addition, Rhyz operates Beauty Biosciences, a beauty company that sells its products through digital and retail channels; LifeDNA, a personalization technology company; and MyFavoriteThings, a social commerce platform. Last year, Rhyz companies generated more than $216 million in sales.

At the end of 2023, Nu Skin had 977,903 customers who purchased directly from the company during the past three months. At the end of Q4, customers decreased 15%, paid affiliates fell 30% and sales leaders declined 10% from 2022.

For the first quarter of 2023, corporate sales fell 13.3% to $417 million. The number of customers dropped 19%.

“Frst quarter revenue came in at the mid-point of our guidance, negatively impacted more than anticipated by foreign currency headwinds. Our cost management efforts helped us post earnings per share in the upper half of our guide,” said CEO Ryan Napierski. “We are continuing our business transformation efforts and making progress in developing our integrated beauty, wellness and lifestyle ecosystem. We again drove strong gains in our Rhyz business, growing nearly 60% year-over-year. In our Nu Skin core business, the macro-economic environment impacted affiliate and customer growth around the globe, but we are encouraged by the performance of AgeLOC WellSpa iO, RenuSpa iO and TRMe launches.”

Sales: $1.0 billion

Sales in Indonesia and the rest of Southeast Asia rose 2% in Q1 2023.

NuSkin products are available in 50 countries. The US accounted for 23% of sales last year. Rounding out the top five markets: Mainland China and Southeast Asia/Pacific (16% each), South Korea (12%) and Japan (10%).

In 2022, Nu Skin’s best-selling beauty top-selling product lines by revenue were AgeLoc LumiSpa devices, AgeLoc Body Spa and Nutricentials skin care products. AgeLoc beauty products accounted for 44% of NuSkin’s beauty product category revenue and 21% of total revenue in 2022.

Unfortunately, the sales decline accelerated in Q1 of 2023. Sales fell 20% to $481 million.

Sales: $1.6 billion

Sales of beauty products fell 3%, but corporate sales rose more than 4% to nearly $2.7 billion. AgeLoc beauty products accounted for 48% of beauty revenue and 26% of total sales. Results benefitted from e-commerce growth, along with the successful launches of AgeLoc Meta and Beauty Focus Collagen+. Together, they added about $119 million to Nu Skin’s top line.

More than skin deep. Nu Skin offers a range of products, including AP 24 toothpaste.

By region, Mainland China accounted for 21% of sales, followed by Americas (20%), South Korea (13%) and Southeast Asia/Pacific (13%), EMEA (11%), Japan (10%) and Hong Kong/Taiwan (6%). Sales in Mainland China fell 9% last year.
Ryan Napierski was named president on September 1, 2021.

For Q1 2022, sales fell 11% to about $605 million.

“We are pleased with our first quarter results, which exceeded guidance,” said Napierski. “Demand remained strong for our most recent product introductions, AgeLoc Meta and Beauty Focus Collagen+, and the momentum from these product launches helped drive strong revenue growth in several markets including the US, Taiwan and Southeast Asia. Our business in Mainland China and several other markets was disrupted due to severe covid-related lockdowns and other factors, and the conflict in Ukraine and Russia negatively impacted business throughout the EMEA.”

Looking ahead, in Q3, Nu Skin launches EmpowerMe, which is billed as a personalized beauty and wellness strategy with connected beauty devices.

Sales: $1.5 billion for cosmetics and personal care products
Corporate sales: $2.5 billion

Corporate sales rose 7% last year, driven by a 47% surge in sales in the Americas/Pacific region as well as a 38% increase in Europe, Middle East and Africa. Personal care sales rose nearly 5% driven by demand for skin care devices.

First quarter 2021 sales soared 31% to a record $677 million. According to CEO Ritch Wood, Nu Skin’s innovative beauty and wellness product initiatives powered by the social commerce business model led to 34% growth in the customer base over the prior year and a 22% increase in global sales leaders.

“We were recognized again by Euromonitor as the world’s number one beauty device systems brand,” added Wood. “We continue to improve our geographic balance, driven by ongoing strong performance in the West, providing a more diversified and sustainable growth profile. Our manufacturing segment also achieved record results with 69% year-over-year revenue growth.”

On September 1, Ryan Napierski will succeed Wood as president and CEO. Wood will remain as an executive advisor through early 2022. Under Wood’s leadership Nu Skin increased its emphasis on being a customer-focused organization; expanded its product innovation, particularly in beauty devices; and transitioned to a digitally enabled social commerce model. He introduced a greater emphasis on sustainability, including reducing the company’s carbon footprint and incorporating environmentally friendly packaging into its products. He also led the company’s efforts to build a more integrated and innovative supply chain through the acquisition of several manufacturing companies.

Napierski has been with Nu Skin for 25 years. He currently serves as president. Prior to that, he served as president of global sales and operations and lived abroad while serving as president of Nu Skin Japan and of Nu Skin’s North Asia region and leading and executing Nu Skin’s strategy in EMEA. Napierski has a bachelor’s degree in business, an MBA from Duke University and a master’s degree in international business from Goethe Universitat in Germany.

In other news, Nu Skin debuted a line of clean beauty products in  with the launch of Nutricentials Bioadaptive Skin Care. Products are made with bioadaptive extracts from plants that thrive in extreme climates to help skin bounce back from daily life stressors, according to Nu Skin.

Sales: $1.4 billion for personal care products.
Corporate sales: $2.4 billion

Corporate sales fell 10% last year, as the number of sales leaders declined 25% and customers dropped 7%. AgeLoc personal care products accounted for 49% of Nu Skin’s personal care revenue and 30% of total revenue last year. International markets accounted for 87% of sales, led by China which accounted for 30% of sales.

The company notes that 80% of global revenue and 90% of global transactions occur online. As a result, in 2020, Nu Skin is focusing on enhancing the customer experience on all of its digital properties.
In March, Nu Skin’s AgeLoc LumiSpa won the NewBeauty Award for best cleansing device.

Reflecting the pandemic’s path, Nu Skin reported a 17% decline in Q1 sales to $518 million. Still, CEO Ritch Wood noted that revenue and earnings were above guidance.

Later this year, Nu Skin will roll out a beauty device system “targeting the emerging skin care enthusiast market.”

For the full year, Nu Skin expects sales to fall 7-10% due to COVID-19.

Sales: $752 million for personal care products.
Corporate sales: $1.3 billion

In 2009, Nu Skin celebrated its 25th anniversary and finished the year on a high note with record revenue, a record launch of its new AgeLoc skin care system and a record number of executive-level distributors, according to sources at the company.

Sales of personal care products jumped 19% to $752.7 million—accounting for 57% of the company’s corporate sales of $1.3 billion.

Globally, Nu Skin products are sold and distributed in 50 markets. In 2009, sales rose 45% to $606.1 million in North Asia, increased 20% to $260.9 million in the Americas, climbed 16% to $210.4 million in Greater China, jumped 10% to $133.6 million in Europe and increased 9% to $120.1 million in South Asia/Pacific.

Indeed it was a milestone year for Nu Skin. Besides celebrating the company’s 25th anniversary with a special convention in Los Angeles, it launched an entirely new class of innovative anti-aging products called “Aging Response Modulators,” or ARMs. This new platform is based on the principle that advanced skin care and nutrition products should go beyond treating the signs and symptoms of aging.

The company’s approach is to identify the ultimate sources of aging located within the human genome.

In the fourth quarter of 2009, Nu Skin introduced an important new ARM for the company—the AgeLoc skin care system, a comprehensive daily skin care regimen clinically demonstrated to improve the appearance of eight signs of aging beginning in only seven days. The enthusiastic demand for these products generated more than $17 million of AgeLoc sales during Nu Skin’s October distributor convention—more than double the convention sales of any prior new product.

“AgeLoc represents the biggest global product launch in Nu Skin history,” said Truman Hunt, Nu Skin president and chief executive officer. “Sales force enthusiasm for our new AgeLoc daily skin care system produced unprecedented demand with sales exceeding our most liberal revenue projections. By developing products with an understanding of the genetic basis of aging through our proprietary AgeLoc science, we believe we are continuing to provide the premier anti-aging business opportunity for our sales representatives—one that represents a ‘sweet spot’ by leveraging a growing global megatrend with exclusive and scientifically validated products that help people look and feel young.”

The company also released a new AgeLoc edition of its bestselling Galvanic Spa System II, an at-home spa unit that provides superior delivery of ageLOC ingredients to the skin and boosts the visible benefits of AgeLoc products.

Nu Skin welcomed Stuart Kim, professor at Stanford University in the departments of Developmental Biology and Genetics, as its newest member of the Nu Skin Anti-Aging Scientific Advisory Board this year. Kim will provide insights on the molecular analysis of aging science. His recent research interests have focused on functional genomics and systems biology.

For the first quarter of 2010, Nu Skin posted a 23% rise in revenue to $364.1 million. Revenue in the Americas rose 7% to $62.5 million.

At press time, Nu Skin named three new presidents. It tapped Luke Yoo to be president of the company’s North Asia region, which includes the company’s businesses in Japan and South Korea. He will fill the role formerly held by Brett Nelson who has been named president of Nu Skin North America. Ryan Napierski has been named as president of Nu Skin Japan, a role also formerly held by Brett Nelson.

In addition to Yoo’s new position as president of the North Asia region, he will continue in his role as president and general manager of the company’s South Korea business. Since 2008, he has served as both vice president of the North Asia region and president of Nu Skin Korea. Yoo joined Nu Skin South Korea in 1999 and has served as president and general manager of Nu Skin’s South Korea operations since 2003.

Prior to his current appointment as president of North America, Nelson served as president of North Asia and president of Nu Skin Japan. He has also served as vice president of global distributor support, president of Southeast Asia, general manager of Canada and vice president of business support and sales.

In his new role, Napierski, a 15-year Nu Skin veteran will continue to focus on objectives, strategies and initiatives that are helping return the company’s Japan business to growth. Prior to his new assignment, Napierski served as vice president of business development for the company’s North Asia region and chief operating officer of Nu Skin Japan.

Sales: $633 million for personal care products.
Corporate sales: $1.2 billion. Net income: $65 million.

Sales of skin care products surged 27% last year and the category now accounts for more than 50% of corporate sales. Sales of Galvanic Spa surged 120% last year to propel skin care sales. Sales of Galvanic Spa System II and Galvanic Spa gels accounted for 26% of Nu Skin’s sales last year.

The company reported strong growth in Europe, the U.S., South Korea and Latin America last year. In fact, 85% of revenues came from outside the U.S. last year. Japan was Nu Skin’s largest market, accounting for 36% of sales.

At the close of fiscal 2008, the company had operations in 48 markets, with plans to enter Turkey, Ukraine and Colombia by mid-2010.

Nu Skin celebrates its 25th anniversary this year and personal care sales were something to celebrate in the first quarter.

“Our personal care business generated solid revenue growth of 19% in the quarter, driven by the continued success of the Nu Skin Galvanic Spa System,” said Truman Hunt, president and chief executive officer. “In addition, our restructuring efforts over the past three years are increasing profitability, as demonstrated by a significant improvement in first-quarter operating margin when excluding restructuring charges.”

Overall, first quarter sales fell 1% to $296.2 million, but Mr. Hunt is convinced that Nu Skin has the technology in place to drive sales forward.

“Our differentiating strategy of going beyond addressing the superficial signs of aging to addressing aging at its source, combined with our proven scientific expertise in both skin care and nutrition, gives us a powerful advantage in the anti-aging arena,” he said.

Nu Skin’s patent-pending Ageloc formula contains an ingredient that inhibits production of Arnox (age-related NADH oxidase), an internal free radical generator that increases in activity as you age, which, according to Nu Skin, makes people who have high levels of it look seven years older than those who don’t.

The Ageloc technology is the result of collaborative research from scientists at Nu Skin and Purdue University, and is designed to inhibit a newly identified age-related enzyme found on external cell membranes, including in the epidermis.

“Consumers in every economic category are spending money on anti-aging products, whether it’s for a $30 jar of cream or invasive treatments costing thousands of dollars, but no solution has yet to do what Ageloc technology offers,” said Ashok Pahwa, chief marketing officer at Nu Skin Enterprises. “We believe Ageloc technology will propel Nu Skin to the forefront of the anti-aging industry by attacking aging where it is happening, before you even see it. Our science is unlocking a secret to how you age.”

This first-to-market anti-aging technology from Nu Skin is the result of more than six years of research and development. Ageloc employs a patent-pending ingredient blend to help diminish the negative visible effects caused by a newly discovered internal source of aging and offers a scientific explanation to why some people may look younger or older than their actual age.

Last month, Nu Skin took its Ageloc message on the road as its top international sales leaders gathered in Saint Petersburg, Russia, to learn how Nu Skin plans to expand its distributor business opportunity with next-generation anti-aging products in both skin care and nutrition that target the ultimate sources of aging.

“We believe that Ageloc is unlocking the secret of youth through our unique understanding of the relationship between aging and certain genes in the human genome, the ultimate sources of aging,” said Mr. Hunt.

Sales: $498 million.
orporate sales: $1.16 billion. Net income: $43.7 million.

This global direct selling company reported a 4% rise in sales. According to Nu Skin’s 2007 annual report, 2007 was a turnaround year for the company. Sales fell in 2006, but Nu Skin’s efforts to generate renewed growth during 2007 were successful. For the year, the company generated a 4% revenue growth, achieving its second-highest revenue year in Nu Skin’s 23-year history.

The company concluded 2007 with sales of $1.16 billion. According to the company, strong performances in most of its markets contributed to these results, including successes in South Korea, the U.S., Eastern Europe, Southeast Asia and Hong Kong. These markets have been able to capitalize on strong product initiatives, including the Galvanic Spa System II, an in-home spa system focused on reducing the visible signs of aging. In addition, the company’s flagship products, the Pharmanex LifePak  multivitamin line and the Nu Skin 180 Skin Care System, continued to hold consumer loyalty.

Nu Skin’s 2007 revenue met its original growth target of 3-5%, notwithstanding larger than anticipated declines in Japan and China. However, its earnings per share (EPS) growth fell short of target. This was due to a lower-than-anticipated gross margin as its revenue mix shifted from Japan to lower-margin markets, and higher-than-expected losses in unprofitable markets, especially China. According to the company, it made significant steps to address these issues in the second half of 2007, putting it on a path to enjoy strong EPS growth in 2008.

Key 2007 re-structuring steps included management changes in key markets of Japan and China, including hiring Gary Sumihiro in Japan to lead business there and 18-year Nu Skin veteran Andrew Fan to head China. In the fourth quarter of 2007, Nu Skin simplified its operations in China by closing approximately 70 stores and reduced its corporate headcount by more than 50%. The company also closed its Brazil operations in mid-2007, with an expected savings of approximately $2 million a year.

The company also launched a new strategic positioning to its distributor leaders at its global convention in September 2007, and is rolling it out globally to its 47 markets in 2008. The initiative includes an updated image and identity for the company.

On the personal care side, Nu Skin has spent the last several years collaborating with scientists at Purdue University to identify an enzyme in the skin known as arNox, which has been shown to be an important contributor to skin aging. This discovery is leading to novel approaches to skin care and company scientists are developing new products based on this new platform with a rollout in key geographies of Japan, Greater China, the Americas and Europe in the next year.